U.S. President Donald Trump announced he will sign an executive order to implement a "Most Favored Nation" policy, aiming to reduce U.S. prescription drug prices to levels seen in other high-income countries, with expected reductions of 30-80%, foreign media reported.

Currently, many U.S. prescription drugs are among the world’s most expensive, nearly three times the cost in other developed nations.

Related NewsCore Producer Prices MoM for April in the United States is -0.4%, lower than the previous value of 0.4%. The forecast was 0.3%.
Trump stated his intent to close this gap but did not publicly specify the methods. Pharmaceutical companies purportedly expect Trump’s latest executive order to focus on the medicare program.